Study of Clinical outcomes and serum concentration of Meropenem in acute kidney injury
Not Applicable
Recruiting
- Conditions
- Acute kidney disease.Acute kidney failure
- Registration Number
- IRCT20160412027346N5
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Acute kidney injury
Recepient of Meropenem
Age over 18 year
Exclusion Criteria
History of chronic kidney disease
Get chronic or emergency dialysis
History of seizure
History of allergy to beta-lactam
Pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum concentration of Meropenem. Timepoint: Measurement of serum concentration of Meropenem in half an hour before and one hour after infusion on three and fifth day of drug injection. Method of measurement: HPLC.
- Secondary Outcome Measures
Name Time Method Clinical outcomes. Timepoint: Daily. Method of measurement: Clinical Pulmonary infection Score.;Serum creatinin. Timepoint: Daily. Method of measurement: Laboratory method.